Question 1

What exactly is NeuroNova?

Accepted Answer

NeuroNova is a chair that sends vibrations through the spine, stimulating certain vertibrae that trigger a release of dopamine in the brain which helps reduce anxiety, improve sleep, increase motivation, and support addiction recovery — all without medication.

Question 2

What does NeuroNova help with?

Accepted Answer

NeuroNova is designed to help with anxiety, low motivation, addiction, and poor sleep — all by restoring natural dopamine levels and calming the nervous system.

Question 3

How does NeuroNova work?

Accepted Answer

NeuroNova uses advanced neuro-harmonic frequencies to naturally stimulate your spine, which sparks dopamine production. It delivers these frequencies directly to your brain stem to promote calm, clarity, and emotional well-being.

Question 4

What makes NeuroNova different from other mental health tools?

Accepted Answer

Unlike apps, supplements, other devices, or medications, NeuroNova works by directly targeting the brain with proven neuromodulation technology via certain vertebrae throughout the spine. It’s drug-free, fast-acting, and backed by 7 years of clinical research.

Question 5

Is NeuroNova safe to use?

Accepted Answer

It has been proven in a clinical trial to have very low risk, as it is non-invasive and non-pharmacological.

Question 6

How soon can I feel results?

Accepted Answer

Many users report noticeable improvements in stress levels, mood, or sleep within the first few sessions. Results may vary based on consistency and individual needs.

Question 7

How long does the effect last?

Accepted Answer

In small pilot studies in humans, dopamine enhancement endures for about 6-7 hours after a treatment of 10 minutes. Continual research is being done to assess the pinpoint effects and duration of the treatment.

Question 8

How often can I treat myself?

Accepted Answer

As often as needed, as there appears to be no side effects of the technology.

FAQs

Here are some of the most frequently asked questions by those interested in NeuroNova.

SUBSCRIBE